Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

US Patent 12351609 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods relating to myomaker-induced muscle cell fusion2022
NURR1 activation in the treatment of metabolic disorders and as an exercise mime2021
NURR1 activation in the treatment of metabolic disorders and as an exercise mime2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Generation and correction of a humanized mouse model with a deletion of dystroph2020
Generation and correction of a humanized mouse model with a deletion of dystroph2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020